This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 May 27;308(5726):1266-7.

doi: 10.1126/science.1113707.

Cell biology. Lessons in rational drug design for protein kinases

Natalie G Ahn¹, Katheryn A Resing

Affiliations

PMID: 15919981
DOI: 10.1126/science.1113707

Comment

Cell biology. Lessons in rational drug design for protein kinases

Natalie G Ahn et al. Science. 2005.

. 2005 May 27;308(5726):1266-7.

doi: 10.1126/science.1113707.

Authors

Natalie G Ahn¹, Katheryn A Resing

Affiliation

¹ Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA. natalie.ahn@colorado.edu

PMID: 15919981
DOI: 10.1126/science.1113707

No abstract available

PubMed Disclaimer

Comment on

Structural bioinformatics-based design of selective, irreversible kinase inhibitors.
Cohen MS, Zhang C, Shokat KM, Taunton J. Cohen MS, et al. Science. 2005 May 27;308(5726):1318-21. doi: 10.1126/science1108367. Science. 2005. PMID: 15919995 Free PMC article.

Similar articles

Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.
Li S, Zhou Y, Lu W, Zhong Y, Song W, Liu K, Huang J, Zhao Z, Xu Y, Liu X, Li H. Li S, et al. J Chem Inf Model. 2011 Nov 28;51(11):2939-47. doi: 10.1021/ci2002445. Epub 2011 Oct 21. J Chem Inf Model. 2011. PMID: 21995341
Structural bioinformatics-based design of selective, irreversible kinase inhibitors.
Cohen MS, Zhang C, Shokat KM, Taunton J. Cohen MS, et al. Science. 2005 May 27;308(5726):1318-21. doi: 10.1126/science1108367. Science. 2005. PMID: 15919995 Free PMC article.
Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity.
Kirrane TM, Boyer SJ, Burke J, Guo X, Snow RJ, Soleymanzadeh L, Swinamer A, Zhang Y, Madwed JB, Kashem M, Kugler S, O'Neill MM. Kirrane TM, et al. Bioorg Med Chem Lett. 2012 Jan 1;22(1):738-42. doi: 10.1016/j.bmcl.2011.10.029. Epub 2011 Oct 18. Bioorg Med Chem Lett. 2012. PMID: 22056746
AKT crystal structure and AKT-specific inhibitors.
Kumar CC, Madison V. Kumar CC, et al. Oncogene. 2005 Nov 14;24(50):7493-501. doi: 10.1038/sj.onc.1209087. Oncogene. 2005. PMID: 16288296 Review.
Structural biology contributions to tyrosine kinase drug discovery.
Cowan-Jacob SW, Möbitz H, Fabbro D. Cowan-Jacob SW, et al. Curr Opin Cell Biol. 2009 Apr;21(2):280-7. doi: 10.1016/j.ceb.2009.01.012. Epub 2009 Feb 7. Curr Opin Cell Biol. 2009. PMID: 19208462 Review.

See all similar articles

Cited by

Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.
Betzi S, Restouin A, Opi S, Arold ST, Parrot I, Guerlesquin F, Morelli X, Collette Y. Betzi S, et al. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19256-61. doi: 10.1073/pnas.0707130104. Epub 2007 Nov 27. Proc Natl Acad Sci U S A. 2007. PMID: 18042718 Free PMC article.
Residue-specific annotation of disorder-to-order transition and cathepsin inhibition of a propeptide-like crammer from D. melanogaster.
Tseng TS, Cheng CS, Hsu ST, Shih MF, He PL, Lyu PC. Tseng TS, et al. PLoS One. 2013;8(1):e54187. doi: 10.1371/journal.pone.0054187. Epub 2013 Jan 21. PLoS One. 2013. PMID: 23349821 Free PMC article.
Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks.
Kanev GK, Zhang Y, Kooistra AJ, Bender A, Leurs R, Bailey D, Würdinger T, de Graaf C, de Esch IJP, Westerman BA. Kanev GK, et al. PLoS Comput Biol. 2023 Sep 5;19(9):e1011301. doi: 10.1371/journal.pcbi.1011301. eCollection 2023 Sep. PLoS Comput Biol. 2023. PMID: 37669273 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.